These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 11343120

  • 1. The lipid phosphatase SHIP2 controls insulin sensitivity.
    Clément S, Krause U, Desmedt F, Tanti JF, Behrends J, Pesesse X, Sasaki T, Penninger J, Doherty M, Malaisse W, Dumont JE, Le Marchand-Brustel Y, Erneux C, Hue L, Schurmans S.
    Nature; 2001 Jan 04; 409(6816):92-7. PubMed ID: 11343120
    [Abstract] [Full Text] [Related]

  • 2. Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis.
    Grempler R, Zibrova D, Schoelch C, van Marle A, Rippmann JF, Redemann N.
    Diabetes; 2007 Sep 04; 56(9):2235-41. PubMed ID: 17596404
    [Abstract] [Full Text] [Related]

  • 3. Impact of transgenic overexpression of SH2-containing inositol 5'-phosphatase 2 on glucose metabolism and insulin signaling in mice.
    Kagawa S, Soeda Y, Ishihara H, Oya T, Sasahara M, Yaguchi S, Oshita R, Wada T, Tsuneki H, Sasaoka T.
    Endocrinology; 2008 Feb 04; 149(2):642-50. PubMed ID: 18039790
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T, Sasaoka T, Funaki M, Hori H, Murakami S, Ishiki M, Haruta T, Asano T, Ogawa W, Ishihara H, Kobayashi M.
    Mol Cell Biol; 2001 Mar 04; 21(5):1633-46. PubMed ID: 11238900
    [Abstract] [Full Text] [Related]

  • 5. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes.
    Sasaoka T, Hori H, Wada T, Ishiki M, Haruta T, Ishihara H, Kobayashi M.
    Diabetologia; 2001 Oct 04; 44(10):1258-67. PubMed ID: 11692174
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T, Kikuchi K, Wada T, Sato A, Hori H, Murakami S, Fukui K, Ishihara H, Aota R, Kimura I, Kobayashi M.
    Endocrinology; 2003 Sep 04; 144(9):4204-14. PubMed ID: 12933696
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity.
    Sleeman MW, Wortley KE, Lai KM, Gowen LC, Kintner J, Kline WO, Garcia K, Stitt TN, Yancopoulos GD, Wiegand SJ, Glass DJ.
    Nat Med; 2005 Feb 04; 11(2):199-205. PubMed ID: 15654325
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2.
    Dyson JM, Kong AM, Wiradjaja F, Astle MV, Gurung R, Mitchell CA.
    Int J Biochem Cell Biol; 2005 Nov 04; 37(11):2260-5. PubMed ID: 15964236
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transcriptional profiling of C2C12 myotubes in response to SHIP2 depletion and insulin stimulation.
    Huard C, Martinez RV, Ross C, Johnson JW, Zhong W, Hill AA, Kim R, Paulsen JE, Shih HH.
    Genomics; 2007 Feb 04; 89(2):270-9. PubMed ID: 17123777
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Developmental defects and rescue from glucose intolerance of a catalytically-inactive novel Ship2 mutant mouse.
    Dubois E, Jacoby M, Blockmans M, Pernot E, Schiffmann SN, Foukas LC, Henquin JC, Vanhaesebroeck B, Erneux C, Schurmans S.
    Cell Signal; 2012 Nov 04; 24(11):1971-80. PubMed ID: 22750293
    [Abstract] [Full Text] [Related]

  • 17. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
    Blero D, Zhang J, Pesesse X, Payrastre B, Dumont JE, Schurmans S, Erneux C.
    FEBS J; 2005 May 04; 272(10):2512-22. PubMed ID: 15885100
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of SH2-domain containing inositol phosphatase 2 (SHIP2) in insulin producing INS1E cells improves insulin signal transduction and induces proliferation.
    Grempler R, Leicht S, Kischel I, Eickelmann P, Redemann N.
    FEBS Lett; 2007 Dec 22; 581(30):5885-90. PubMed ID: 18061583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.